Literature DB >> 103487

Juvenile neuroaxonal dystrophy: clinical, electrophysiological, and neuropathological features.

L J Dorfman, T A Pedley, B R Tharp, B W Scheithauer.   

Abstract

We describe 2 brothers with progressive myoclonus epilepsy that began in the second decade and was associated with cerebellar ataxia and intellectual deterioration. Electroencephalographic and cerebral evoked potential studies showed findings associated with myoclonus epilepsy. Neuropathological examination of 1 of the brothers, who died at age 23 years, revealed widespread changes of neuroaxonal dystrophy without pigment deposition in the basal ganglia. We propose the term juvenile neuroaxonal dystrophy (JNAD) to distinguish this condition on clinical grounds from infantile neuroaxonal dystrophy on the one hand, and on clinical and pathological grounds from Hallervorden-Spatz disease on the other hand. JNAD, while exceedinly rare, must be considered in the differential diagnosis of the progressive myoclonus epilepsies.

Entities:  

Mesh:

Year:  1978        PMID: 103487     DOI: 10.1002/ana.410030511

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  Spinal neuroaxonal dystrophy and angioneuromatosis.

Authors:  J J Martin; P Cras; E De Schutter
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  PLA2G6 mutation underlies infantile neuroaxonal dystrophy.

Authors:  Shareef Khateeb; Hagit Flusser; Rivka Ofir; Ilan Shelef; Ginat Narkis; Gideon Vardi; Zamir Shorer; Rachel Levy; Aharon Galil; Khalil Elbedour; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2006-09-19       Impact factor: 11.025

Review 3.  Rare causes of dystonia parkinsonism.

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

4.  Intracranial calcification in paediatric computed tomography.

Authors:  B Kendall; N Cavanagh
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.